Crop Life Science Limited (NSE:CLSL)
India · Delayed Price · Currency is INR 70.95
+3.35 (4.96%)
Oct 21, 2026, 2:34 PM IST
Crop Life Science Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,072 | 2,006 | 1,986 | 1,312 | 1,020 |
Other Revenue | 2.39 | 1.01 | - | 0 | - |
| 2,074 | 2,007 | 1,986 | 1,312 | 1,020 | |
Revenue Growth | 3.35% | 1.05% | 51.35% | 28.64% | -14.23% |
Cost of Revenue | 1,522 | 1,422 | 1,467 | 925.23 | 598.3 |
Gross Profit | 552.27 | 584.66 | 518.88 | 387.03 | 421.8 |
Selling, General & Admin | 152.76 | 155.2 | 140.47 | 128.52 | 135.52 |
Other Operating Expenses | 218.4 | 262.33 | 252.14 | 138.57 | 208.93 |
Operating Expenses | 420.57 | 465.79 | 424.88 | 304.15 | 366.96 |
Operating Income | 131.69 | 118.87 | 94 | 82.88 | 54.84 |
Interest Expense | -49.69 | -43.86 | -29.03 | -30.7 | -19.54 |
Interest & Investment Income | 1.92 | 3.75 | 13.34 | 5.34 | 0.11 |
Currency Exchange Gain (Loss) | 12.37 | 3 | - | 0.28 | 0.54 |
Other Non Operating Income (Expenses) | -4.59 | -3.67 | -2.51 | -1.82 | 1.34 |
EBT Excluding Unusual Items | 91.7 | 78.1 | 75.8 | 55.97 | 37.28 |
Gain (Loss) on Sale of Assets | - | - | 5.03 | - | 0.4 |
Other Unusual Items | 0.63 | -0.14 | 0.24 | - | 0 |
Pretax Income | 92.32 | 77.96 | 81.07 | 55.97 | 37.69 |
Income Tax Expense | 27.37 | 21.95 | 20.91 | 15.26 | 9.55 |
Earnings From Continuing Operations | 64.95 | 56.01 | 60.16 | 40.71 | 28.14 |
Minority Interest in Earnings | 1.4 | 2.91 | 0.08 | - | - |
Net Income | 66.35 | 58.92 | 60.23 | 40.71 | 28.14 |
Net Income to Common | 66.35 | 58.92 | 60.23 | 40.71 | 28.14 |
Net Income Growth | 12.62% | -2.19% | 47.95% | 44.67% | -24.04% |
Shares Outstanding (Basic) | 17 | 17 | 17 | 12 | 12 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 12 | 12 |
Shares Change | - | - | 42.83% | - | - |
EPS (Basic) | 3.87 | 3.44 | 3.51 | 3.39 | 2.35 |
EPS (Diluted) | 3.87 | 3.44 | 3.51 | 3.39 | 2.35 |
EPS Growth | 12.62% | -2.19% | 3.66% | 44.56% | -24.04% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -95.54 | -54.01 | -157.73 | -27.42 | -45.13 |
Free Cash Flow Per Share | -5.57 | -3.15 | -9.20 | -2.29 | -3.76 |
Gross Margin | 26.63% | 29.13% | 26.13% | 29.49% | 41.35% |
Operating Margin | 6.35% | 5.92% | 4.73% | 6.32% | 5.38% |
Profit Margin | 3.20% | 2.94% | 3.03% | 3.10% | 2.76% |
Free Cash Flow Margin | -4.61% | -2.69% | -7.94% | -2.09% | -4.42% |
EBITDA | 170.21 | 156.73 | 126.82 | 106.71 | 73.09 |
EBITDA Margin | 8.21% | 7.81% | 6.39% | 8.13% | 7.17% |
D&A For EBITDA | 38.51 | 37.86 | 32.82 | 23.83 | 18.25 |
EBIT | 131.69 | 118.87 | 94 | 82.88 | 54.84 |
EBIT Margin | 6.35% | 5.92% | 4.73% | 6.32% | 5.38% |
Effective Tax Rate | 29.65% | 28.15% | 25.80% | 27.26% | 25.33% |
Revenue as Reported | 2,089 | 2,016 | 2,007 | 1,320 | 1,024 |